Clinical significance of diastolic wall strain in heart failure with preserved ejection fraction: A cross-sectional observational analysis

舒张期室壁应变在射血分数保留型心力衰竭中的临床意义:一项横断面观察分析

阅读:1

Abstract

BACKGROUND: Diastolic wall strain (DWS) is based on linear elastic theory, which shows that impaired diastolic wall thinning reflects resistance to deformation in diastole and thus, increased diastolic myocardial stiffness. We aim to explore the role of DWS in patients with heart failure with preserved ejection fraction (HFpEF) in terms of correlation with indices of HFpEF. METHODS: Study enrolled 53 patients with exertional dyspnoea and normal left ventricular ejection fraction. Forty patients fulfilled the criteria for HFpEF according to ESC 2023 criteria. RESULTS: Two groups were analysed - Group 1 with criteria of HFpEF fulfilled and Group 2 with those who did not. Echocardiographic indices including relative wall thickness (RWT), left ventricular mass index (LVMI), E/e', left atrial volume index (LAVI) and DWS were numerically different on comparison with group 2, with LVMI, LAVI and E/e' statistically significant. Also mean Global Longitudinal Strain (GLS) was found to be -13.05%. Group 1 was divided into HFpEF with DWS ≤ median and HFpEF with DWS > median. Echocardiographic indices showed statistically higher LVMI and atrial filling fraction. This finding showed that patients with reduced DWS were more likely to have diastolic dysfunction. Also, it was found that DWS had a statistically significant correlation with LVMI, LAVI and RWT. Lower DWS had abnormal GLS. Limitations include small sample size. CONCLUSION: Although difference in DWS between HFpEF and controls did not reach statistical significance, stratification by median value showed significant correlation of DWS with myocardial relaxation parameters. Also, with significant correlation with increased atrial filling fraction higher N-terminal pro-B type natriuretic peptide and correlation with impaired GLS, our study supports DWS as a potential research tool in evaluation of HFpEF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。